Growth Metrics

Boston Scientific (BSX) Depreciation & Amortization (CF) (2020 - 2026)

Boston Scientific's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $351.0 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 8.0% to $351.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 billion, a 8.06% increase, with the full-year FY2025 number at $1.4 billion, up 7.8% from a year prior.
  • Depreciation & Amortization (CF) hit $351.0 million in Q1 2026 for Boston Scientific, down from $365.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for BSX hit a ceiling of $365.0 million in Q4 2025 and a floor of $274.0 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $312.9 million across 5 years, with a median of $306.0 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): grew 1.38% in 2022 and later increased 11.76% in 2025.
  • Tracing BSX's Depreciation & Amortization (CF) over 5 years: stood at $294.0 million in 2022, then rose by 6.46% to $313.0 million in 2023, then rose by 11.18% to $348.0 million in 2024, then increased by 4.89% to $365.0 million in 2025, then dropped by 3.84% to $351.0 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for BSX at $351.0 million in Q1 2026, $365.0 million in Q4 2025, and $342.0 million in Q3 2025.